Retreatment with alemtuzumab after a first, successful alemtuzumab treatment in B-CLL

被引：0
|
作者：
Fiegl, Michael [1 ]
Falkner, Florian [1 ]
Falkner, Andreas [1 ]
Zojer, Niklas [2 ]
Fridrik, Michael [3 ]
Hopfinger, Georg [4 ]
Stauder, Reinhard [5 ]
Gunsilius, Ebehard [5 ]
Kantner, Johanna [5 ]
Erdel, Martin [5 ]
Tinhofer, Inge [6 ]
Gastl, Guenther [5 ]
Greil, Richard [6 ]
机构：
[1] Acad Natters Hosp Tyrol, Natters, Austria
[2] Wilhelminenspital Stadt Wien, Vienna, Austria
[3] Gen Hosp Linz, Linz, Austria
[4] Hanuschspital, Vienna, Austria
[5] Med Univ Hosp, Innsbruck, Austria
[6] Med Univ Hosp, Salzburg, Austria
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4714
引用
收藏
页码：252B / 252B
页数：1
相关论文
共 50 条
  • [21] Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab
    Shukla, Neerav
    Kobos, Rachel
    Renaud, Thomas
    Teruya-Feldstein, Julie
    Price, Anita
    McAllister-Lucas, Linda
    Steinherz, Peter
    CANCER, 2012, 118 (15) : 3719 - 3724
  • [22] Successful treatment of cancer-associated retinopathy with alemtuzumab
    Ladan Espandar
    Susan O’Brien
    Charles Thirkill
    Linda A. Lubecki
    Bita Esmaeli
    Journal of Neuro-Oncology, 2007, 83 : 295 - 302
  • [23] FINAL RESULTS OF ORAL FLUDARABINE WITH CONCOMITANT SUBCUTANEOUS ALEMTUZUMAB IN RELAPSED/REFRACTORY B-CHRONIC LYMPHOCYTIC LEUKAEMIA (B-CLL): THE FLUSALEM STUDY
    Egle, A.
    Melchardt, T.
    Pleyer, L.
    Tinhofer, I.
    Lang, A.
    Keil, F.
    Thaler, J.
    Gunsilius, E.
    Fridrik, M.
    Greil, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 140 - 140
  • [24] Activity and safety of combined fludarabine and alemtuzumab followed by low-dose alemtuzumab maintenance therapy in patients with B-CLL.
    Kowal, Malgorzata
    Dmoszynska, Anna
    BLOOD, 2006, 108 (11) : 337B - 337B
  • [25] Symptomatic Thrombocytopenia After One Dose of Alemtuzumab With Successful Rechallenge
    Derlet, Andrea
    Agius, Mark
    Apperson, Michelle
    NEUROLOGY, 2017, 88
  • [26] Mycobacterium haemophilum Infection after Alemtuzumab Treatment
    Kamboj, Mini
    Louie, Eddie
    Keihn, Timothy
    Papanicolaou, Genovefa
    Glickman, Michael
    Sepkowitz, Kent
    EMERGING INFECTIOUS DISEASES, 2008, 14 (11) : 1821 - 1823
  • [27] Listeria Meningitis with Aspergillosis After Alemtuzumab Treatment
    Kilic, Ahmet Kasim
    Kara, Tugce
    Barut, Banu Ozen
    TURKISH JOURNAL OF NEUROLOGY, 2022, 28 (01) : 55 - 56
  • [28] Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
    Jung, Chul Won
    Cho, Su-Hee
    Park, Sylvia
    Jang, Jun Ho
    Ji, Jun Ho
    BLOOD RESEARCH, 2016, 51 (04) : 297 - 299
  • [29] Lack of Lymphopenia Following First Phase of Treatment with Alemtuzumab
    Stone, Joshua
    Cahill, Jonathan
    Rizvi, Syed
    NEUROLOGY, 2018, 90
  • [30] Alemtuzumab as First Line Treatment in Children with Familial Lymphohistiocytosis
    Moshous, Despina
    Briand, Coralie
    Castelle, Martin
    Dupic, Laurent
    Morelle, Guillaume
    Abou Chahla, Wadih
    Barlogis, Vincent
    Bertrand, Yves
    Bruno, Benedicte
    Jeziorski, Eric
    Paillard, Catherine
    Rohrlich, Pierre Simon
    Stephan, Jean Louis
    Thomas, Caroline
    Chhun, Stephanie
    Pellier, Isabelle
    Marie-Cardine, Aude
    Fusaro, Mathieu
    de Saint Basile, Genevieve
    Picard, Capucine
    Elie, Caroline
    Neven, Benedicte
    Blanche, Stephane
    Fischer, Alain
    BLOOD, 2019, 134
12345